(R, S) -Ivosidenib
Ivosidenib is a targeted inhibitor of mutant IDH1 used in research for acute myeloid leukemia (AML) . The (R, S) -enantiomer is the less active form of this compound, serving as a useful control in both in vitro enzymatic assays and in vivo xenograft studies to elucidate the specific effects of the active drug.
Product Specifications
CAS Number
2070009-31-1
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Smiles
Fc1cncc (c1) N ([C@@H] (C (=O) NC1CC (F) (F) C1) c1ccccc1Cl) C (=O) [C@@H]1CCC (=O) N1c1cc (ccn1) C#N
Molecular Formula
C28H22ClF3N6O3
Molecular Weight
582.96
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog